ClinicalTrials.gg
Active, not recruitingNCT07693699Updated Nov 18, 2026

Optimizing Sustainable Cuff Access and Training Pathways for Self-Measured Blood Pressure Monitoring in Primary Care

An interventional study of Unscheduled AI Flyer and Scheduled AI Flyer in Hypertension, sponsored by Wake Forest University Health Sciences. Active, not recruiting at 6 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 18, 2026Now Active, not recruitingPrimary completion moved+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
155
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 25 studies in Hypertension by Wake Forest University Health Sciences — 4 open to participants now, 7 under way, none of them phase 3. Hypertension · Wake Forest University Health Sciences.

Enrollment
4th of 20
155 · median 41
Started
2026
with 2 others
No phase
17 of 25
3 open now
Registered
25th of 25
by date

Among the 25 studies in Hypertension by Wake Forest University Health Sciences, this one is the 4th largest by enrollment of the 20 interventional ones that give a count, is one of 3 that started in 2026, is one of 17 with no phase, and was the 25th registered.

Hypertension

6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.

Browse Hypertension studies →

Open to participants now

4 of the 25 studies in Hypertension by Wake Forest University Health Sciences are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 552 Hypertension studies recruiting now, 260 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 136 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Hypertension by Wake Forest University Health Sciences, or all of them as a file.
02

Study summary

The goal of this study is to evaluate AI Virtual Assistant-supported blood pressure reading return pathways that support delivery of a SMBP program in routine primary care, among adult primary care patients with uncontrolled hypertension

03

Conditions studied

  • Hypertension

Browse trials for

Keywords

  • blood pressure cuff
  • blood pressure cuff delivery
  • blood pressure cuff instruction
04

Who can participate

The criteria were revised on the registry on Nov 18, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older.
  • Diagnosed hypertension documented prior to the index clinic visit.
  • Scheduled for and attends a visit with a participating clinician at a study clinic.

Exclusion criteria

Exclusion Criteria

  • No study-specific exclusion criteria are anticipated beyond failure to meet inclusion criteria
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
155 participants (actual)

Study arms

  • Active comparator
    Unscheduled AI Virtual Assistant Call

    Patients will be provided an educational infographic and AI Virtual Assistant flyer. No specific AI outreach date or time is scheduled with the patient.

    Behavioral: Unscheduled AI Flyer

  • Active comparator
    Participant Scheduled AI Virtual Assistant Call

    Patients will be provided an educational infographic and an AI Virtual Assistant flyer. The MA or RA will work with the patient to identify a preferred date and time for AI outreach and document the scheduled outreach time on the flyer.

    Behavioral: Scheduled AI Flyer

Interventions

  • BehavioralUnscheduled AI Flyer

    Provide patient with an AI flyer

  • BehavioralScheduled AI Flyer

    The MA or RA will work with the patient to identify a preferred date and time for AI outreach and document the scheduled outreach time on the flyer.

06

What researchers measure

Primary outcomes

  1. SMBP Reading Return

    Proportion of randomized patients with a home blood pressure reading obtained through AI Virtual Assistant outreach and documented in the EHR.

    Time frame: 14 Days

Secondary outcomes

  1. AI Virtual Assistant Engagement

    Proportion of randomized patients who complete the AI Virtual Assistant call.

    Time frame: 14 Days

  2. SMBP Reading Return Among Engaged Patients

    Among patients who complete the AI Virtual Assistant call, proportion who provide a home blood pressure reading.

    Time frame: 14 Days

  3. SMBP Reading Documentation at 3 Months

    Proportion of patients with any SMBP reading documented in Epic.

    Time frame: 3 Months

  4. Home BP Cuff Access

    Proportion of patients reporting access to a home blood pressure cuff.

    Time frame: 21 Days

  5. Distribution of Cuff Access Pathways

    Distribution of patients who: already own a cuff, accept insurance-supported acquisition assistance, plan independent purchase, or do not wish to obtain a cuff.

    Time frame: Enrollment

  6. Workflow Implementation

    Completion of key workflow activities, including cuff-access assessment, randomization assignment, flyer distribution, and AI outreach completion.

    Time frame: 3 Months

Other outcomes

  1. Change in Systolic Blood Pressure

    Change in systolic blood pressure using routinely documented clinic measurements.

    Time frame: 3 Months

  2. Medication Intensification

    Addition of an antihypertensive medication, dose increase, or regimen intensification.

    Time frame: 3 Months

07

Study locations

6 sites
  • Advocate Medical Group Chicago (Southeast)
    Chicago, Illinois 60617, United States
  • Advocate Medical Group Chicago (Imani Village)
    Chicago, Illinois 60619, United States
  • Advocate Medical Group Beverly
    Chicago, Illinois 60643, United States
  • Advocate Medical Group Merrionette Park
    Merrionette Park, Illinois 60803, United States
  • Advocate Medical Group Oak Lawn (FP)
    Oak Lawn, Illinois 60453, United States
  • Advocate Medical Group Oak Lawn (IM)
    Oak Lawn, Illinois 60453, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Dec 2026, 4 months after the start.

Of 1,407 non-industry interventional studies with no phase under Hypertension, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 4 months is below that.

Counting every sponsor, half of 1,502 studies reached it within 23 months; a quarter within 10 and three quarters within 42.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion Oct 2026 → Dec 2026 and completion Nov 2026 → Feb 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 2, 2026
First posted
Jul 9, 2026
StartActual
Jul 30, 2026
Primary completionEst.
Dec 1, 2026was Oct 2026
CompletionEst.
Feb 6, 2027was Nov 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Active, not recruiting
changed Nov 18, 2026
Primary completion
Oct 20, 2026→Dec 1, 2026
Nov 18, 2026
Study completion
Nov 20, 2026→Feb 6, 2027
Nov 18, 2026
Enrollment
150 (estimated)→155 (actual)
Nov 18, 2026
Eligibility
1 inclusion criterion edited, 1 removed; 1 exclusion criterion added, 5 removed
What changed in the criteria
Inclusion criteria
  • EditedScheduled for and attends an in-persona visit with a participating clinician at a study clinic.
  • RemovedElevated BP (blood pressure) documented in Epic during rooming or the clinic visit before study enrollment, defined as systolic BP >=140 mmHg or diastolic BP >=90 mmHg.
Exclusion criteria
  • RemovedVisit is canceled, rescheduled, or the patient does not attend the visit.
  • RemovedPatient already has a usable home BP cuff provide through insurance within the past 5 years.
  • RemovedPatient declines assistance obtaining a BP cuff.
  • RemovedPatient declines submitting cuff order to insurance.
  • RemovedPatient unable to participate for operational reasons.
  • AddedNo study-specific exclusion criteria are anticipated beyond failure to meet inclusion criteria
Nov 18, 2026
Interventions
Added Behavioral: Unscheduled AI Flyer·Behavioral: Scheduled AI Flyer; removed Behavioral: In-Clinic Cuff Delivery - Enhanced Return Conversation·Behavioral: In-Clinic Cuff Delivery - Written Instructions·Behavioral: Mail Order Cuff Delivery - Enhanced Return Conversation·Behavioral: Mail Order Cuff Delivery - Written Instructions. Arms added: Unscheduled AI Virtual Assistant Call·Participant Scheduled AI Virtual Assistant Call; arms removed: Mail-order cuff delivery - Enhanced Return Conversation·Mail-order cuff delivery - Written instructions·In-clinic cuff distribution - Enhanced Return Conversation·In-clinic cuff distribution - Written instructions
Nov 18, 2026
Primary outcomes
1 added, 3 removed
What changed in the outcomes
  • AddedSMBP Reading ReturnTime frame: 14 Days
  • RemovedRate of Blood Pressure ReceiptTime frame: up to day 14
  • RemovedRate of Return Modality CompletionTime frame: up to day 14
  • RemovedRate of Cuff Order CompletionTime frame: up to day 14
Nov 18, 2026
Secondary outcomes
1 edited, 1 time frame changed, 6 added, 6 removed, 1 description edited
What changed in the outcomes
  • AddedAI Virtual Assistant EngagementTime frame: 14 Days
  • AddedSMBP Reading Return Among Engaged PatientsTime frame: 14 Days
  • AddedSMBP Reading Documentation at 3 MonthsTime frame: 3 Months
  • AddedHome BP Cuff AccessTime frame: 21 Days
  • AddedDistribution of Cuff Access PathwaysTime frame: Enrollment
  • AddedWorkflow ImplementationTime frame: 3 Months
  • RemovedTime to Complete InterventionTime frame: up to day 14
  • RemovedNumber of Participants Documenting at Least One Blood Pressure ReadingTime frame: up to day 21
  • RemovedTime Between Cuff Receipt and First Documented ReadingTime frame: up to day 21
  • RemovedRate of Workflow BarriersTime frame: up to day 14
  • RemovedRate of FidelityTime frame: up to day 14
  • RemovedRate of Differential Implementation SuccessTime frame: up to day 14
  • Editedother outcomeRate of Medication IntensificationTime frame: up to day 90 → 3 Months
  • Time frameother outcomeChange in Systolic Blood Pressureup to day 90 → 3 Months
  • Descriptionother outcomeChange in Systolic Blood Pressure: how it is measured was reworded
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Recruiting→Active, not recruiting
    Primary completion Oct 20, 2026→Dec 1, 2026
    Study completion Nov 20, 2026→Feb 6, 2027
    Enrollment 150 (estimated)→155 (actual)
    Eligibility 1 inclusion criterion edited, 1 removed; 1 exclusion criterion added, 5 removed
    What changed in the criteria
    Inclusion criteria
    • EditedScheduled for and attends an in-persona visit with a participating clinician at a study clinic.
    • RemovedElevated BP (blood pressure) documented in Epic during rooming or the clinic visit before study enrollment, defined as systolic BP >=140 mmHg or diastolic BP >=90 mmHg.
    Exclusion criteria
    • RemovedVisit is canceled, rescheduled, or the patient does not attend the visit.
    • RemovedPatient already has a usable home BP cuff provide through insurance within the past 5 years.
    • RemovedPatient declines assistance obtaining a BP cuff.
    • RemovedPatient declines submitting cuff order to insurance.
    • RemovedPatient unable to participate for operational reasons.
    • AddedNo study-specific exclusion criteria are anticipated beyond failure to meet inclusion criteria
    Primary outcomes 1 added, 3 removed
    What changed in the outcomes
    • AddedSMBP Reading ReturnTime frame: 14 Days
    • RemovedRate of Blood Pressure ReceiptTime frame: up to day 14
    • RemovedRate of Return Modality CompletionTime frame: up to day 14
    • RemovedRate of Cuff Order CompletionTime frame: up to day 14
    Secondary outcomes 1 edited, 1 time frame changed, 6 added, 6 removed, 1 description edited
    What changed in the outcomes
    • AddedAI Virtual Assistant EngagementTime frame: 14 Days
    • AddedSMBP Reading Return Among Engaged PatientsTime frame: 14 Days
    • AddedSMBP Reading Documentation at 3 MonthsTime frame: 3 Months
    • AddedHome BP Cuff AccessTime frame: 21 Days
    • AddedDistribution of Cuff Access PathwaysTime frame: Enrollment
    • AddedWorkflow ImplementationTime frame: 3 Months
    • RemovedTime to Complete InterventionTime frame: up to day 14
    • RemovedNumber of Participants Documenting at Least One Blood Pressure ReadingTime frame: up to day 21
    • RemovedTime Between Cuff Receipt and First Documented ReadingTime frame: up to day 21
    • RemovedRate of Workflow BarriersTime frame: up to day 14
    • RemovedRate of FidelityTime frame: up to day 14
    • RemovedRate of Differential Implementation SuccessTime frame: up to day 14
    • Editedother outcomeRate of Medication IntensificationTime frame: up to day 90 → 3 Months
    • Time frameother outcomeChange in Systolic Blood Pressureup to day 90 → 3 Months
    • Descriptionother outcomeChange in Systolic Blood Pressure: how it is measured was reworded
    Interventions Added Behavioral: Unscheduled AI Flyer·Behavioral: Scheduled AI Flyer; removed Behavioral: In-Clinic Cuff Delivery - Enhanced Return Conversation·Behavioral: In-Clinic Cuff Delivery - Written Instructions·Behavioral: Mail Order Cuff Delivery - Enhanced Return Conversation·Behavioral: Mail Order Cuff Delivery - Written Instructions. Arms added: Unscheduled AI Virtual Assistant Call·Participant Scheduled AI Virtual Assistant Call; arms removed: Mail-order cuff delivery - Enhanced Return Conversation·Mail-order cuff delivery - Written instructions·In-clinic cuff distribution - Enhanced Return Conversation·In-clinic cuff distribution - Written instructions
    + 5 other changes: verification date, description, design details, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07693699
Responsible party
Sponsor
First posted
Jul 9, 2026
Start date
Jul 30, 2026
Primary completion
Dec 1, 2026 (estimated)
Completion
Feb 6, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Rasha Khatib, PhD
principal investigator · Advocate Health

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion